Leukemia CancerConnect
COVID-19 Vaccination in Patients with Blood Cancers
Studies of COVID-19 vaccine effectiveness in myeloma and lymphoma available - vaccine relatively ineffective.
Treatment of Childhood Acute Lymphoblastic Leukemia
Cancer Connect - Treatment of Childhood Acute Lymphoblastic Leukemia
Venclexta Combination Treatment for Chronic Lymphocytic Leukemia
Sustained progression free and overall survival benefits with Venclexta combined with Rituxan or Imbruvica.
Leukemia Cancer Connect is a unique resource that brings patients, caregivers, advocates and experts together in a single community where individuals benefit from a blend of expert-authored news and educational programming alongside a robust social network, providing insight into symptoms, diagnosis, treatment, and the support of other individuals being treated at some of the best cancer centers. Leukemia Cancer Connect offers users expert authored clinically-reviewed information and the perspective of their peers in a safe, objective space, helping to ensure they become empowered in their healthcare journey.
Leukemia Cancer Connect is a unique resource that brings patients, caregivers, advocates and experts together in a single community where individuals benefit from a blend of expert-authored news and educational programming alongside a robust social network, providing insight into symptoms, diagnosis, treatment, and the support of other individuals being treated at some of the best cancer centers. Leukemia Cancer Connect offers users expert authored clinically-reviewed information and the perspective of their peers in a safe, objective space, helping to ensure they become empowered in their healthcare journey.
Leukemia Overviews
Acute Myeloid Leukemia: Overview and Treatment
Management of Acute Myeloid Leukemia: Induction, Consolidation, Precision Medicines and Stem Cell Transplantation.
Treatment of Adult Acute Lymphoblastic Leukemia
Cancer Connect - Treatment of Adult Acute Lymphoblastic Leukemia
Acute Myeloid Leukemia Treatment Options Expand With Recent FDA Approvals
FDA Approves Venclexta, Daurismo, and Xospata Precision Cancer Medicines for Treatment of Acute Myeloid Leukemia
Chronic Myeloid Leukemia
Diagnosis, useful terms and treatment of chronic myeloid leukemia - chronic phase.
Acute Leukemia
Blincyto Prolongs Survival in Acute Lymphoblastic Leukemia (ALL)
Studies continue to demonstrate that incorporation of Blincyto into ALL treatment improves patient outcomes.
Vidaza® May Provide Alternative Treatment for Elderly Patients with AML
Vidaza® May Provide Alternative Treatment for Elderly Patients with AML.
Venclexta® for Acute Myeloid Leukemia
Venclexta® expands treatment options for AML - ASCO 2020 update in elderly AML patients confirms benefit.
FDA Approves Mylotarg for Treatment of Acute Myeloid Leukemia
FDA Approves Mylotarg for Treatment of Acute Myeloid Leukemia
Chronic Leukemia
Treatment of Childhood Acute Lymphoblastic Leukemia
Cancer Connect - Treatment of Childhood Acute Lymphoblastic Leukemia
Venclexta Combination Treatment for Chronic Lymphocytic Leukemia
Sustained progression free and overall survival benefits with Venclexta combined with Rituxan or Imbruvica.
Imbruvica® Effective in Newly Diagnosed & Recurrent Chronic Lymphocytic Leukemia
Imbruvica® Rituxan combination superior to FCR chemotherapy for treatment of newly diagnosed CLL
Zelboraf® Appears Active in Hairy That Has Progressed After Other Treatment
Zelboraf® Appears Active in Hairy Cell Leukemia That Has Progressed After Other Treatment
Leukemia Survivorship
COVID-19 Vaccination in Patients with Blood Cancers
Studies of COVID-19 vaccine effectiveness in myeloma and lymphoma available - vaccine relatively ineffective.
Ask the Expert: Fertility after Cancer Treatment
Dr Leslie Diller M.D. of Dana Farber Cancer Center discusses cancer and fertility.
Cancer and Fertility Options for Women
Overview of fertility options for women diagnosed with cancer from Memorial Sloan Kettering's Cancer & Fertility Program
Do CLL Patients Have an Increased Risk of Developing a New Cancer?
CLL patients are at increased risk of developing a new cancer including those taking Ibrutinib & BTK Inhibitors